about
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patientsLiver resection and ablation for metastatic melanoma: A single center experiencePembrolizumab: first global approval.Pembrolizumab: A Review in Advanced Melanoma.Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies.Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.Glutamate and asparagine cataplerosis underlie glutamine addiction in melanomaA phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.Problems of Differential Diagnosis in Melanoma Arising from Blue Naevus.In silico studies of the interaction between BRN2 protein and MORE DNA.Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review
P2860
Q36140846-FE6ED0E5-9F80-4A26-BB9D-2DAB63D34C01Q36173638-94930E7C-9C08-4FEA-AA8F-EEA149CC907AQ36184101-94B40858-E266-4FA0-8262-E8E81133BC0BQ36700481-CE508E0D-5D92-4E58-BD9C-606C8177B048Q36779843-3634A171-9A8B-418D-8B5E-D03C18B61794Q37518270-B5EC1549-415E-4F13-8D99-8014BCCDA425Q38261580-D3DBE6D4-5DA6-4AFC-80D3-BC421EAAA672Q38723299-EBB2375F-880F-4538-9F78-8EF6B77BD7B7Q38770017-FD389780-E642-4AEE-AFBD-4568161D3C34Q38860973-EB97CF60-4D39-41D0-8C6E-F214810A141AQ42406273-5FA8A742-9776-432E-B8E1-8F76A3E9B88AQ46046772-A3889D50-263C-4C32-B5D7-9D081D92C9B4Q47566725-35265F69-0933-4DBE-8566-AAD5BB4E6E9CQ48588744-FBEE9DBB-31AF-4400-A9CF-0C5C08EBCFABQ50213075-9AD43B38-87D3-4915-B3F1-70DE7D791EF8Q51546451-FA0751AA-EFC6-44CB-8E81-A0034047290EQ58865491-97597E16-FF2D-4E13-971C-5D251C40D35A
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A review of novel therapies for melanoma.
@ast
A review of novel therapies for melanoma.
@en
A review of novel therapies for melanoma.
@nl
type
label
A review of novel therapies for melanoma.
@ast
A review of novel therapies for melanoma.
@en
A review of novel therapies for melanoma.
@nl
prefLabel
A review of novel therapies for melanoma.
@ast
A review of novel therapies for melanoma.
@en
A review of novel therapies for melanoma.
@nl
P2093
P2860
P1476
A review of novel therapies for melanoma.
@en
P2093
Chante Karimkhani
Rene Gonzalez
Robert P Dellavalle
P2860
P2888
P304
P356
10.1007/S40257-014-0083-7
P577
2014-08-01T00:00:00Z
P6179
1051468955